ES2103724T3 - Ligandos a los receptores de dopamina y agentes formadores de imagenes. - Google Patents

Ligandos a los receptores de dopamina y agentes formadores de imagenes.

Info

Publication number
ES2103724T3
ES2103724T3 ES90302807T ES90302807T ES2103724T3 ES 2103724 T3 ES2103724 T3 ES 2103724T3 ES 90302807 T ES90302807 T ES 90302807T ES 90302807 T ES90302807 T ES 90302807T ES 2103724 T3 ES2103724 T3 ES 2103724T3
Authority
ES
Spain
Prior art keywords
dopamine
receivers
linked
image forming
forming agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90302807T
Other languages
English (en)
Inventor
Hank F Kung
Raymond Murphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Application granted granted Critical
Publication of ES2103724T3 publication Critical patent/ES2103724T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE DESCUBREN NUEVOS RECEPTORES D-2 DE DOPAMINA CNS, TALES COMO EL COMPUESTO 5-YODO-7-N[(1-ETILO-2PIRROLIDINILO)METILO]CARBOXAMIDA-2,3-DIHIDROBENZOFURANO. ESTOS COMPUESTOS SE EMPLEAN COMO AGENTES DE IMAGINACION MEDIANTE RECEPTORES D-2 EN EL CEREBRO HUMANO Y EXHIBEN BUENA RETENCION CEREBRAL Y ESTABILIDAD EN VIVO.FIG 1.
ES90302807T 1989-04-17 1990-03-15 Ligandos a los receptores de dopamina y agentes formadores de imagenes. Expired - Lifetime ES2103724T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/339,006 US5122361A (en) 1989-04-17 1989-04-17 Dopamine receptor ligands and imaging agents

Publications (1)

Publication Number Publication Date
ES2103724T3 true ES2103724T3 (es) 1997-10-01

Family

ID=23327058

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90302807T Expired - Lifetime ES2103724T3 (es) 1989-04-17 1990-03-15 Ligandos a los receptores de dopamina y agentes formadores de imagenes.

Country Status (11)

Country Link
US (3) US5122361A (es)
EP (1) EP0393838B1 (es)
JP (1) JPH0662560B2 (es)
KR (1) KR930002491B1 (es)
AT (1) ATE154802T1 (es)
CA (1) CA2011745C (es)
DE (1) DE69030963T2 (es)
DK (1) DK0393838T3 (es)
ES (1) ES2103724T3 (es)
GR (1) GR3024008T3 (es)
HK (1) HK1007745A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03128558U (es) * 1990-04-06 1991-12-25
US6531483B1 (en) * 1990-08-09 2003-03-11 Research Triangle Institute Cocaine receptor binding ligands
US7189737B2 (en) * 1991-08-09 2007-03-13 Research Triangle Institute Cocaine receptor binding ligands
FR2682953B1 (fr) * 1991-10-23 1995-04-21 Inst Nat Sante Rech Med Nouveaux derives de naphtamides, leur procede de preparation et leur application dans le domaine therapeutique.
EP0625149A1 (en) * 1992-02-06 1994-11-23 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists
US5446147A (en) * 1992-04-03 1995-08-29 Trustees Of The University Of Pennsylvania Fluorinated and iodinated dopamine agents
US5993777A (en) * 1993-05-06 1999-11-30 Research Corporation Technologies, Inc. Benzamide compounds for cancer imaging and therapy
CA2139503A1 (en) * 1993-05-06 1994-11-24 Christy S. John Compounds for cancer imaging and therapy
US5911970A (en) 1993-05-06 1999-06-15 Research Corporation Technologies, Inc. Methods for cancer imaging and therapy using benzamine compounds
US6517811B2 (en) 1993-05-06 2003-02-11 Research Corporation Technologies, Inc. Compounds for cancer imaging and therapy
GB9320855D0 (en) * 1993-10-09 1993-12-01 Smithkline Beecham Plc Compounds
US7105678B2 (en) 1995-11-03 2006-09-12 Organix, Inc. Boat tropanes
US5948933A (en) 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
US6171576B1 (en) * 1995-11-03 2001-01-09 Organix Inc. Dopamine transporter imaging agent
US5919934A (en) * 1997-02-19 1999-07-06 The George Washington University Compounds, compositions, and methods for cancer imaging and therapy
WO1999055355A1 (en) 1998-04-24 1999-11-04 3-Dimensional Pharmaceuticals, Inc. Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
JP4554077B2 (ja) 1998-06-11 2010-09-29 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ピラジノンプロテアーゼインヒビター
CA2721484A1 (en) 1999-05-12 2000-11-12 President And Fellows Of Harvard College Dopamine transporter imaging agents
DE60005351D1 (de) 1999-07-09 2003-10-23 Dimensional Pharm Inc Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel
WO2002070020A2 (en) * 2001-03-02 2002-09-12 University Of Western Ontario Polymer precursors of radiolabeled compounds, and methods of making and using the same
DE20120708U1 (de) 2001-10-09 2002-08-01 Blundell, Paul, Sommerville, Mass. Tropan-Analoga zur Inhibierung des Monoamin-Transports
US20040248850A1 (en) * 2003-02-11 2004-12-09 Kemia, Inc. Compounds for the treatment of HIV infection
JP2006522809A (ja) 2003-04-10 2006-10-05 ３−ディメンショナル ファーマシューティカルズ， インコーポレイテッド 置換フェニルアセトアミおよびプロテアーゼインヒビターとしてのその使用
CA2599321A1 (en) * 2005-02-28 2006-09-08 Taisho Pharmaceutical Co. Ltd. Radioactive halogen-labeled phenyloxyaniline derivatives
WO2007109459A2 (en) * 2006-03-21 2007-09-27 Janssen Pharmaceutica, Nv Pyridines and pyridine n-oxides as modulators of thrombin
TW201406770A (zh) * 2012-08-01 2014-02-16 Inst Nuclear Energy Res Atomic Energy Council 造影劑之標幟前驅物及其製備方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891671A (en) * 1968-08-01 1975-06-24 Ile De France N-(2-pyrrolidyl or piperidyl alkyl)-4-hydroxy benzamides
GB1374366A (en) * 1972-07-21 1974-11-20 Science Union & Cie Propanol derivatives and a process for their preparation
SE8205135D0 (sv) * 1982-09-09 1982-09-09 Astra Laekemedel Ab Benzamido-derivatives
JPS59186969A (ja) * 1983-04-08 1984-10-23 Yoshitomi Pharmaceut Ind Ltd ベンゾフラン−およびベンゾピランカルボキサミド誘導体
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
CA1297877C (en) * 1983-12-22 1992-03-24 Daniel Lednicer Benzofurancarboxamides useful as antiemetic or antipsychotic agents
US4656280A (en) * 1984-03-07 1987-04-07 E. I. Du Pont De Nemours And Company Radioiodinated dopamine receptor ligand
SE8503054D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Catecholcarboxamides
SE8503055D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Piperonylcarboxamido derivatives
JPS6248684A (ja) * 1985-08-26 1987-03-03 Sumitomo Chem Co Ltd 新規なヨ−ドブチロフエノン誘導体およびその製造法
FR2593504B1 (fr) * 1986-01-30 1988-12-09 Ile De France Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
EP0320630A1 (en) * 1987-11-19 1989-06-21 The Vanderbilt University Enantiometric iodobenzamides

Also Published As

Publication number Publication date
CA2011745A1 (en) 1990-10-17
ATE154802T1 (de) 1997-07-15
US5122361A (en) 1992-06-16
US5334728A (en) 1994-08-02
DE69030963D1 (de) 1997-07-31
AU5229290A (en) 1990-10-18
GR3024008T3 (en) 1997-10-31
EP0393838B1 (en) 1997-06-25
DK0393838T3 (da) 1997-08-25
JPH02292256A (ja) 1990-12-03
EP0393838A1 (en) 1990-10-24
US5426189A (en) 1995-06-20
KR900016192A (ko) 1990-11-12
KR930002491B1 (ko) 1993-04-02
DE69030963T2 (de) 1997-11-27
AU622301B2 (en) 1992-04-02
JPH0662560B2 (ja) 1994-08-17
CA2011745C (en) 1997-12-16
HK1007745A1 (en) 1999-04-23

Similar Documents

Publication Publication Date Title
ES2103724T3 (es) Ligandos a los receptores de dopamina y agentes formadores de imagenes.
YU157191A (sh) Antagonisti receptora fibrinogena
ATE38672T1 (de) 7-oxabicycloheptan aminosubstituierte prostaglandinaehnliche verbindungen.
ES2147759T3 (es) Heterociclos no aromaticos sustituidos con aminometileno y uso como antagonistas de la sustancia p.
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
IT1166551B (it) Procedimento per la fabbricazione di impiantati nonche' impiantati realizzati con detto procedimento
PH15562A (en) New hydroxyethyl-azole compounds,their production and their medicinal use
ZA772074B (en) New pour-on formulations of anthelmintics
ZA796356B (en) New hydroxypropyl-triazole compounds, their production and their medicinal use
SE8307146D0 (sv) 7-oxabicykloheptan-substituerade aminoprostaglandinanaloger
FI884720A7 (fi) Varjoaineina käytettäviä koostumuksia
FR2455587A1 (fr) Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
FR2397411A1 (fr) Composes tricycliques derives du norbornane, leur utilisation et procede pour leur preparation
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FI902291A7 (fi) Heterosyklisiä guanidiinejä 5HT3-antagonisteina
IT1174301B (it) Proccedimento per produrre polipropi lene di migliore stirabilita'
IT1107463B (it) Pirrolo (2/1-b)(3)benzazepine composizioni e procedimento per la loro preparazione
IT1158450B (it) Procedimento per la preparazione dell'eritro-alfa-2-piperidil-2,8-bis-(trifluorometil)-4-chinolinmetanolo
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
ES2061712T3 (es) Nuevos derivados sustituidos de 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
ES449432A1 (es) Un procedimiento para la preparacion de nuevas benzazepinas.
ES2146722T3 (es) Nuevos analogos de la acronicina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69031399D1 (de) Dopamin-Rezeptor-Liganden und Bilderzeugungsmittel
SE7701504L (sv) Antihypertensiva medel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 393838

Country of ref document: ES